Search Results
CodeBreaK 100: Patient-reported outcomes evaluating sotorasib in KRAS p.G12C mNSCLC
CodeBreaK100 trial: Evaluating Sotorasib in pretreated KRAS p.G12C mNSCLC
Phase II CodeBreak 100 trial of sotorasib in advanced NSCLC
Sotorasib outperforms docetaxel in previously treated KRAS-mutated NSCLC | Melissa Johnson
Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer
Sotorasib for KRAS G12C-Mutated Lung Cancer
KRAS G12C Inhibition in Advanced NSCLC: AMG 510
CodeBreak 200 | Sotorasib | A Negligent trial that violated randomization!
Expert Video Report on therapeutic advances in NSCLC from 2021 ASCO Annual Meeting
Sotorasib for KRAS G12C Mutated Advanced Non-Small Cell Lung Cancer
Future perspectives in lung cancer
Targeting non-G12C KRAS mutations in NSCLC
